about
Anorexia of aging: a modifiable risk factor for frailtyCharacteristics of adults with down syndrome: prevalence of age-related conditionsFunctional changes during hospital stay in older patients admitted to an acute care ward: a multicenter observational study.Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.A multicomponent approach to identify predictors of hospital outcomes in older in-patients: a multicentre, observational studyBone mineral density in adults with Down syndrome.Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia.Association of frailty with the serine protease HtrA1 in older adults.Use of ACE-inhibitors and falls in patients with Parkinson's disease.Herbal Medications in Cardiovascular Medicine.Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization.Inappropriate Use of Proton Pump Inhibitors in Elderly Patients Discharged from Acute Care Hospitals.Association of metabolic syndrome with falls in patients with Parkinson's disease.Use of proton-pump inhibitors is associated with depression: a population-based study.Chronic diseases and geriatric syndromes: The different weight of comorbidity.Impact of hospitalization on modification of drug regimens: Results of the criteria to assess appropriate medication use among elderly complex patients study.Physical Restraint and Antipsychotic Medication Use Among Nursing Home Residents With Dementia.Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease.Inappropriate pharmacological treatment in older adults affected by cardiovascular disease and other chronic comorbidities: a systematic literature review to identify potentially inappropriate prescription indicators.Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study.Prescription drug use among older adults in Italy: a country-wide perspective.Polypharmacy and health outcomes among older adults discharged from hospital: results from the CRIME study.Dopaminergic agents and nutritional status in Parkinson's disease.Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study.Use of benzodiazepines and cognitive performance in primary care patients with first cognitive complaints.Health determinants and survival in nursing home residents in Europe: Results from the SHELTER study.Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus.Role of anticholinergic burden in primary care patients with first cognitive complaints.The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease.An international perspective on chronic multimorbidity: approaching the elephant in the room.Polypharmacy in Home Care in Europe: Cross-Sectional Data from the IBenC Study.Poor adherence to chronic obstructive pulmonary disease medications in primary care: Role of age, disease burden and polypharmacy.Quality indicators for community care for older people: A systematic review.Anticholinergic burden and health outcomes among older adults discharged from hospital: results from the CRIME study.Metabolic syndrome and quality of life in the elderly: age and gender differences.Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity.Predictors of length of hospital stay among older adults admitted to acute care wards: a multicentre observational study.Rapidly developing multimorbidity and disability in older adults: does social background matter?Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study.Accounting for frailty when treating chronic diseases.
P50
Q27023156-7F9B1BC4-A73A-4C57-B7DC-1F23FA23AA06Q28652311-6875AC77-B4EE-4302-BB71-5659B14D3225Q33600133-1CEB34DB-97B0-4F55-8EE6-DBE621283323Q33845468-A18CCE9B-231B-435B-AB44-2C60267F00F0Q34776096-3258FDC9-58F7-46B6-8621-93C5F6976840Q38690073-047F1D02-3943-498A-8D34-D62FCEC0BBCDQ38825946-D913BD9F-0252-44B2-B13C-B082DC67447AQ38883957-2AEDBC71-8E65-49C3-9177-FC7F683A0425Q38930612-5ACBCCBC-E7AC-4FB8-B182-669473082E6AQ38932714-DE143339-414F-4218-9215-15F574EFFAFEQ39076795-E0525EB0-35A9-4F4A-8442-41BD6F2CFB74Q39702517-8A492FED-1FB2-4707-A67E-688CB5565DA4Q39974986-60E450CC-164A-4E46-922D-1377B47B6433Q40045059-F7B28CC6-E4EC-41A9-97C9-92EB45ACCDB5Q40235798-8E118FBB-D130-4262-A2AD-2D6F763EF7D7Q40897213-6FD0D0D1-11F8-4D59-8C13-B4CF63B96ED3Q40969704-A8BC838D-042E-446F-9401-E65F67368164Q41416504-B4D9E1D9-C855-4822-8A02-08830E3481DCQ43063161-07D47E0A-BD6C-42F6-8503-BCBB922D9D08Q43522765-87A353BE-B7AC-431A-A05D-10FA582EA393Q44337647-9CD27AFA-1873-47BC-AF73-C4146DDBF0F9Q44424321-80D91007-4837-4651-80B9-4445E0DCF82DQ46069066-640B6A05-91CD-4432-89AC-14215C97C91FQ47099751-9499674F-99D6-4735-9F2E-6F2CB73F92E5Q47577837-7F498382-04A2-46A7-A4E1-009AB39FF797Q47601195-811A9C14-6238-4F91-AE8B-951DF655EF3CQ47716705-6EF591D0-D272-422D-B98B-3DDC7E229816Q47723092-721B8C5D-326C-463B-80AE-961CAFE09581Q47822209-D6E99FDD-1078-4B00-9B79-AA74A729F6F8Q47924928-DCEB160C-B808-4DC6-B8F4-5F22CC1486CCQ48092462-3E0EA484-13FD-4566-944A-FF6CA92C585FQ48213382-BFDD5DFB-9A58-495E-A362-77A8F4EC77D9Q48284025-7B52681A-4487-4972-A9AF-03CCDC68E035Q48308894-D0CFB1EB-A2C5-4711-BCD8-D1601BC14373Q48469995-11985C79-4124-40C1-8D8D-9B985C570644Q48507482-C26D45E5-C6C2-4C08-9BEF-93758702A2C0Q49111869-14863396-8D3A-4E3D-B5F4-646C3350079EQ50055255-11BEAE07-07AB-418E-A0E9-680CBD0ABB47Q51093278-FC012401-3755-4E1C-82B8-3C3DDB2839A2Q51764230-D0FA2098-CBEA-434D-882B-B9FA3065A17D
P50
description
investigador
@es
onderzoeker
@nl
researcher
@en
name
Davide L Vetrano
@ast
Davide L Vetrano
@en
Davide L Vetrano
@es
Davide L Vetrano
@nl
type
label
Davide L Vetrano
@ast
Davide L Vetrano
@en
Davide L Vetrano
@es
Davide L Vetrano
@nl
altLabel
Davide Liborio Vetrano
@en
prefLabel
Davide L Vetrano
@ast
Davide L Vetrano
@en
Davide L Vetrano
@es
Davide L Vetrano
@nl
P1053
K-7417-2016
P106
P1153
55058027700
P31
P4012
P496
0000-0002-3099-4830